Spire Healthcare Group stock

SPI · LSE · GBp

Compare Spire Healthcare Group
249.50 GBpChange from previous close: +0.81%Absolute change: +2.00 GBp

Close · November 20, 2026

Price history

+12.90% over the period

1 year: from 221.00 GBp (November 20, 2025) to 249.50 GBp (November 20, 2026), +12.90%.

Show chart data

Closing prices adjusted for splits: the last close of each month.

DateClose
November 20, 2026249.50 GBp
October 30, 2026249.00 GBp
September 30, 2026246.50 GBp
August 28, 2026235.00 GBp
July 31, 2026233.50 GBp
June 30, 2026215.00 GBp
May 29, 2026221.00 GBp
April 30, 2026163.00 GBp
March 31, 2026146.00 GBp
February 27, 2026203.00 GBp
January 30, 2026204.00 GBp
December 31, 2025167.00 GBp
November 28, 2025229.50 GBp
November 20, 2025221.00 GBp

At a glance

  • The company

    Owns and operates private hospitals and clinics in the UK, providing diagnostics, inpatient and outpatient care across multiple specialties

  • Latest results

    Quarter to June 30, 2026 · EPS -£0.01

TickerLandia's take on Spire Healthcare Group

Analysis calculated by TickerLandia from financial statements and prices, with public rules. Not investment advice. How we analyse stocks

Where the price stands

52-wk low140.80 GBp
52-wk high249.50 GBp

0.00% from the 52-week high

Analysts · 4 analysts

Average target258.00 GBp+3.41% vs. price

Buy 1 · Hold 3 · Sell 0 · Buy

TickerLandia Fingerprint: Spire Healthcare Group

Compared with similar companies: very low financial strength and very low growth.

Financials and price compared with 19 companies in the medical care facilities industry, worldwide. Momentum and risk compared with 1,160 European stocks.

Position in the group from 0 to 100 (100 = highest value): it describes, it does not rate. Tap a row for the metrics. Calculated on November 22, 2026. An indicator calculated by TickerLandia from financial statements and market data. How it is calculated

Valuation

Spire Healthcare Group is pricier than in the past and in line with similar companies

On the latest fiscal year's earnings (2025), Spire Healthcare Group's P/E today is 62.4, above the median of its last 7 fiscal years (41.8; between 25.4 and 108.6 from 2016 to 2025). Spire Healthcare Group's Forward P/E: 14.4, in line with the median of a group of 10 similar companies (13.8).

P/E compared with its history

Compared with 10 similar companies

Spire Healthcare Group's metrics compared with similar companies
MetricSpire Healthcare GroupPosition in the groupBand
Forward P/E14.4Middle
Operating margin7.6%Low
ROE-0.2%Low
Debt/equity1.80Middle
Price/book1.37Low

P/E at fiscal year end; today on the latest fiscal year's earnings. Grey band: the middle half of the group; tick: the median; dot: Spire Healthcare Group. All multiples and dividends

TickerLandia analysisHow it is calculated

The financials

The business in numbers

Revenue

£792.7M

Latest quarter · Q2 2026

Net income

-£11.8M

Latest quarter · Q2 2026

Quarterly net margin

-1.5%

Latest quarter · Q2 2026

Numbers and valuation

Full valuation
Market cap
£991.48M
EPS
0.00 GBp
Volume
436.34K
Daily trading
€2.99M
Dividend yield
0.60%
Last ex-dividend on May 21, 2026

How Spire Healthcare Group is changing

All results
  • Revenue grew 11.4% a year on average over the last 5 years

  • Revenue has grown for 5 fiscal years in a row

  • Profitable in 4 of 5 fiscal years

Returns

Spire Healthcare Group returns with dividends

£1,000 invested in Spire Healthcare Group 5 years ago, on November 22, 2021, would be worth £1,053 today with dividends reinvested: +5.25% in total, +1.03% per year. On price alone it would be £1,023 (+2.25%).

PeriodSpire Healthcare GroupFTSE 100£1,000 becomes
1 month+0.81%−3.60%£1,008
6 months+12.90%−0.82%£1,129
Year to date+49.40%+4.18%£1,494
1 year+13.66%+8.59%£1,137
3 years+12.39%+38.02%£1,124
5 years+5.25%+42.60%£1,053
10 years−24.53%+52.65%£755

Over the last 6 months it has done better than 43% of the stocks in the Healthcare sector.

From 1 year up with dividends reinvested, before taxes; under a year price only. FTSE 100: price only. Calculate your investment

The chart in detail

Spire Healthcare Group: technical analysis

Spire Healthcare Group is in an uptrend: the price is above its 50- and 200-session moving averages, and the 200-session average is rising. The price is 37.9% below its all-time closing high (401.60 GBp, August 20, 2015).

Trend
Upward
RSI (14 sessions)
68
Between 30 and 70
vs 200-session average
+16.69%

Active signals

  • New 52-week high.

  • The price is moving in an unusually narrow range compared with the last year.

    since September 30, 2026

  • Trading on November 20, 2026 was 4.5 times the 20-session average.

Support and resistance

Price areas where Spire Healthcare Group has stopped several times in the last year. They describe the chart; they are not forecasts.

  1. No resistance above: the price is near the highs of the year
  2. Last price249.50 GBp
  3. Support246.03 GBp−1.39%15 touches, last on November 6, 2026
  4. Support237.00 GBp−5.01%2 touches, last on August 6, 2026
  5. Support229.38 GBp−8.07%4 touches, last on August 24, 2026

Volatility and risk

Over the last year it has moved less than the FTSE 100.

Beta (1 year) vs FTSE 100
0.56
Volatility (60 sessions, annualised)
8.5%
Largest fall in the last year
−37.78%

Close of November 20, 2026. Descriptive data calculated on daily prices: it describes the chart and is not investment advice. Beta and volatility describe the last year and can change a lot from one year to the next. How we calculate it

Spire Healthcare Group: seasonality

Average monthly price change over 13 years

+1.6%Jan−2.2%Feb−4.8%Mar+5.0%Apr+6.7%May−1.8%Jun+0.8%Jul+0.1%Aug−0.7%Sep+2.5%Oct+1.0%Nov+1.3%Dec

Over the last 13 years, the strongest month for Spire Healthcare Group has been May: +6.70% on average, positive in 9 years out of 12. The weakest has been March: −4.79% on average, positive in 6 years out of 12. November, the current month, has been positive in 7 years out of 12 (+1.02% on average).

Show chart data
MonthAverageMedianPositive years
January+1.56%+3.42%7 of 12
February−2.18%−1.83%3 of 12
March−4.79%+0.53%6 of 12
April+4.97%+6.89%9 of 12
May+6.70%+2.36%9 of 12
June−1.80%−3.71%4 of 12
July+0.79%+0.01%6 of 12
August+0.10%−0.46%6 of 13
September−0.71%+3.49%8 of 13
October+2.51%+0.70%7 of 13
November+1.02%+4.31%7 of 12
December+1.33%+1.01%7 of 12

Price change only, dividends excluded. Past seasonality does not predict future moves.

The company

Spire Healthcare Group and its competitors

Its Hospitals Business segment owns and operates private hospitals and clinics across the United Kingdom, offering diagnostics, inpatient, day case and outpatient care in orthopaedics, cardiology, oncology, gynaecology and general surgery, alongside treatments such as hip and knee replacement, cataract removal, cosmetic surgery and weight loss procedures. Its hospitals also serve patients in areas such as neurology, neurosurgery, urology and vascular surgery. The Primary Care segment provides GP services, occupational health and mental and physical health services to outpatients.

Headquarters
London, United Kingdom
Employees
17,800
Founded
2007
Chief executive
David Sloman
Spire Healthcare Group and its competitors
CompanyMarket capOperating marginP/E (trailing 12 months)6 months
Spire Healthcare GroupSPI$1.3B7.6%—+12.90%
TerveystaloTTALO$830.61M8.9%13.0−27.00%
MedicoverMCOV.B$3.82B7.4%38.3+19.86%
Fresenius Medical CareFME$10.72B10.1%12.3−2.36%
FreseniusFRE$31.8B9.9%18.4+27.91%
Mouwasat Medical Services4002$3.16B25.8%13.5−14.59%

Same industry or related industries, similar size. Compare Spire Healthcare Group with its competitors · Full profile